These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2847457)
1. Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure. Lane DA; Ireland H; Tew CJ; Flynn A; Curtis JR Acta Chir Scand Suppl; 1988; 543():101-4. PubMed ID: 2847457 [TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222. Ireland H; Lane DA; Flynn A; Pegrum AC; Curtis JR Thromb Haemost; 1988 Apr; 59(2):240-7. PubMed ID: 2838924 [TBL] [Abstract][Full Text] [Related]
3. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis. Ryan KE; Lane DA; Flynn A; Shepperd J; Ireland HA; Curtis JR Thromb Haemost; 1991 Sep; 66(3):277-82. PubMed ID: 1745997 [TBL] [Abstract][Full Text] [Related]
5. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation. Lane DA; Ireland H; Flynn A; Anastassiades E; Curtis JR Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient. Nowak G; Bucha E; Brauns I; Czerwinski R Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807 [TBL] [Abstract][Full Text] [Related]
7. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay. Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456 [TBL] [Abstract][Full Text] [Related]
8. [Comparative study of low molecular weight heparin and unfractionated heparin in patients on maintenance hemodialysis]. Noguchi M; Izumi K; Deguchi K; Endoh T; Tsuda M; Shirakawa S Rinsho Byori; 1990 Jul; Suppl 86():177-83. PubMed ID: 2172594 [No Abstract] [Full Text] [Related]
9. [Use of low-molecular weight heparin during hemodialysis]. Kalinowski M; Pawlak K; Myśliwiec M; Popławski A Pol Merkur Lekarski; 1997 Jan; 2(9):208-10. PubMed ID: 10907031 [TBL] [Abstract][Full Text] [Related]
10. A low molecular heparin fraction as an anticoagulant during hemodialysis. Ljungberg B Clin Nephrol; 1985 Jul; 24(1):15-20. PubMed ID: 4017295 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure. Ryan KE; Lane DA; Flynn A; Ireland H; Boisclair M; Shepperd J; Curtis JR Thromb Haemost; 1992 Nov; 68(5):563-9. PubMed ID: 1455403 [TBL] [Abstract][Full Text] [Related]
12. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis. Ljungberg B; Blombäck M; Johnsson H; Lins LE Clin Nephrol; 1987 Jan; 27(1):31-5. PubMed ID: 3815906 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of low molecular weight heparin anticoagulation during haemodialysis with a Sonoclot Analyzer. Schött U; Nilsson LG; Broman M; Engström M Perfusion; 2010 Jul; 25(4):191-6. PubMed ID: 20530518 [TBL] [Abstract][Full Text] [Related]
15. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane. Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457 [TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage]. Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482 [TBL] [Abstract][Full Text] [Related]
17. [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk]. Steinbach G; Bosc C; Caraman PL; Azoulay E; Olry L; D'Azemar P; Chopin J Nephrologie; 1990; 11(1):17-21. PubMed ID: 2165223 [TBL] [Abstract][Full Text] [Related]
18. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis. Stefoni S; Cianciolo G; Donati G; Colì L; La Manna G; Raimondi C; Dalmastri V; Orlandi V; D'Addio F Nephron; 2002; 92(3):589-600. PubMed ID: 12372942 [TBL] [Abstract][Full Text] [Related]
19. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients. Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433 [TBL] [Abstract][Full Text] [Related]
20. On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure. Lane DA; Flynn A; Ireland H; Anastassiades E; Curtis JR Haemostasis; 1986; 16 Suppl 2():38-47. PubMed ID: 3744134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]